Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day

← catalyst calendar

NCT03878446 · results posted

Sponsored by Novo Nordisk A/S (industry) · NVO — their whole pipeline →.

Phase
Phase 2
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
62actual
Sites
95
Countries
Algeria, Austria, Canada +20

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2019-07-04actualWhen the study began enrolling
Primary completion2021-05-05actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2026-12-23estimatedThe whole study's end, after follow-up
First posted2019-03-18actualWhen this record first appeared on the registry
Results posted2024-06-20actualWhen the sponsor posted results to the registry
Record updated2026-08-13actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Short Stature Children Born Small for Gestational Age (SGA)

Interventions

  • Drug: Somapacitan
  • Drug: Norditropin®

Primary outcome

what the primary-completion date above is the date OF
Height Velocity
measured Baseline (week 0); week 26

Posted documents

hosted by the registry — we link, never re-serve
Study Protocol and Statistical Analysis Planposted 2020-06-12 · 3.6 MB · Prot_SAP_000.pdf

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · NVO's whole pipeline · Catalyst calendar · Every registered study · What changed